ArticleJournal for immunotherapy of cancer2022

Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.

Katarina Pinjusic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.